106 related articles for article (PubMed ID: 9394799)
1. Rapamycin inhibits proteasome activator expression and proteasome activity.
Wang X; Omura S; Szweda LI; Yang Y; Bérard J; Seminaro J; Wu J
Eur J Immunol; 1997 Nov; 27(11):2781-6. PubMed ID: 9394799
[TBL] [Abstract][Full Text] [Related]
2. Properties of the beta subunit of the proteasome activator PA28 (11S REG).
Wilk S; Chen WE; Magnusson RP
Arch Biochem Biophys; 2000 Dec; 384(1):174-80. PubMed ID: 11147828
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of the proteasome activator PA28 is required for proteasome activation.
Li N; Lerea KM; Etlinger JD
Biochem Biophys Res Commun; 1996 Aug; 225(3):855-60. PubMed ID: 8780702
[TBL] [Abstract][Full Text] [Related]
4. Reconstitution of hybrid proteasomes from purified PA700-20 S complexes and PA28alphabeta activator: ultrastructure and peptidase activities.
Kopp F; Dahlmann B; Kuehn L
J Mol Biol; 2001 Oct; 313(3):465-71. PubMed ID: 11676531
[TBL] [Abstract][Full Text] [Related]
5. Proteasome inhibitor induced gene expression profiles reveal overexpression of transcriptional regulators ATF3, GADD153 and MAD1.
Zimmermann J; Erdmann D; Lalande I; Grossenbacher R; Noorani M; Fürst P
Oncogene; 2000 Jun; 19(25):2913-20. PubMed ID: 10871842
[TBL] [Abstract][Full Text] [Related]
6. Molecular cloning of proteasome activator PA28-beta subunit of large yellow croaker (Pseudosciana crocea) and its coordinated up-regulation with MHC class I alpha-chain and beta 2-microglobulin in poly I:C-treated fish.
Liu G; Zheng W; Chen X
Mol Immunol; 2007 Feb; 44(6):1190-7. PubMed ID: 16901544
[TBL] [Abstract][Full Text] [Related]
7. The proteasome activator 11 S REG (PA28) and class I antigen presentation.
Rechsteiner M; Realini C; Ustrell V
Biochem J; 2000 Jan; 345 Pt 1(Pt 1):1-15. PubMed ID: 10600633
[TBL] [Abstract][Full Text] [Related]
8. Properties of the proteasome activator subunit PA28 alpha and its des-tyrosyl analog.
Wilk S; Chen WE; Magnusson RP
Arch Biochem Biophys; 1998 Nov; 359(2):283-90. PubMed ID: 9808770
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of bovine PA28 on six peptidase activities of the lobster muscle proteasome (multicatalytic proteinase).
Mykles DL
Arch Biochem Biophys; 1996 Jan; 325(1):77-81. PubMed ID: 8554345
[TBL] [Abstract][Full Text] [Related]
10. The proteasome activator 11 S REG or PA28: chimeras implicate carboxyl-terminal sequences in oligomerization and proteasome binding but not in the activation of specific proteasome catalytic subunits.
Li J; Gao X; Joss L; Rechsteiner M
J Mol Biol; 2000 Jun; 299(3):641-54. PubMed ID: 10835274
[TBL] [Abstract][Full Text] [Related]
11. The role of the proteasome system and the proteasome activator PA28 complex in the cellular immune response.
Kloetzel PM; Soza A; Stohwasser R
Biol Chem; 1999 Mar; 380(3):293-7. PubMed ID: 10223331
[TBL] [Abstract][Full Text] [Related]
12. Rapamycin inhibits the generation of graft-versus-host disease- and graft-versus-leukemia-causing T cells by interfering with the production of Th1 or Th1 cytotoxic cytokines.
Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Vallera DA
J Immunol; 1998 Jun; 160(11):5355-65. PubMed ID: 9605135
[TBL] [Abstract][Full Text] [Related]
13. MEKK3 interacts with the PA28 gamma regulatory subunit of the proteasome.
Hagemann C; Patel R; Blank JL
Biochem J; 2003 Jul; 373(Pt 1):71-9. PubMed ID: 12650640
[TBL] [Abstract][Full Text] [Related]
14. Tannic acid potently inhibits tumor cell proteasome activity, increases p27 and Bax expression, and induces G1 arrest and apoptosis.
Nam S; Smith DM; Dou QP
Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1083-8. PubMed ID: 11588135
[TBL] [Abstract][Full Text] [Related]
15. Primary structures of two homologous subunits of PA28, a gamma-interferon-inducible protein activator of the 20S proteasome.
Ahn JY; Tanahashi N; Akiyama K; Hisamatsu H; Noda C; Tanaka K; Chung CH; Shibmara N; Willy PJ; Mott JD
FEBS Lett; 1995 Jun; 366(1):37-42. PubMed ID: 7789512
[TBL] [Abstract][Full Text] [Related]
16. Geldanamycin abrogates ErbB2 association with proteasome-resistant beta-catenin in melanoma cells, increases beta-catenin-E-cadherin association, and decreases beta-catenin-sensitive transcription.
Bonvini P; An WG; Rosolen A; Nguyen P; Trepel J; Garcia de Herreros A; Dunach M; Neckers LM
Cancer Res; 2001 Feb; 61(4):1671-7. PubMed ID: 11245482
[TBL] [Abstract][Full Text] [Related]
17. Lactacystin increases LDL receptor level on HepG2 cells.
Miura H; Tomoda H; Miura K; Takishima K; Omura S
Biochem Biophys Res Commun; 1996 Oct; 227(3):684-7. PubMed ID: 8885994
[TBL] [Abstract][Full Text] [Related]
18. Proteasome inhibitors block VCAM-1 and ICAM-1 gene expression in endothelial cells without affecting nuclear translocation of nuclear factor-kappa B.
Cobb RR; Felts KA; Parry GC; Mackman N
Eur J Immunol; 1996 Apr; 26(4):839-45. PubMed ID: 8625976
[TBL] [Abstract][Full Text] [Related]
19. The proteasome inhibitor PI31 competes with PA28 for binding to 20S proteasomes.
Zaiss DM; Standera S; Holzhütter H; Kloetzel P; Sijts AJ
FEBS Lett; 1999 Sep; 457(3):333-8. PubMed ID: 10471803
[TBL] [Abstract][Full Text] [Related]
20. Relationship of the 20S proteasome and the proteasome activator PA28 to atherosclerosis and intimal hyperplasia in the human vascular system.
Faries PL; Rohan DI; Wyers MC; Marin ML; Hollier LH; Quist WC; LoGerfo FW
Ann Vasc Surg; 2001 Nov; 15(6):628-33. PubMed ID: 11769143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
